LMLin Mu

Lin Mu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lin Mu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comprehensive analysis of immune-related genes reveals diagnostic biomarkers and molecular subtypes in diabetic retinopathy

    by Lin Mu, Zhe Wang, Yaojiani Cao, Xuejun Wang, Xingtao Zhou

    Diabetic retinopathy (DR) is a common microvascular complication of diabetes and one of the primary causes of vision loss; however, its pathogenic mechanisms remain largely unresolved. In recent years, immune dysregulation has been increasingly recognized to be closely associated with DR progression. In the present study, we integrated two GEO datasets to identify immune-related differentially expressed genes (DEGs) associated with DR. After batch effect correction and differential expression analysis, a total of 123 immune-related DEGs were identified. Functional enrichment analysis demonstrated that these genes are primarily associated with immune activation pathways, such as T-cell receptor signaling, natural killer cell–mediated cytotoxicity, and IL-17 signaling. Using least absolute shrinkage and selection operator (LASSO) regression, five key genes (IL10RA, PLAUR, PLAU, VTN, and VGF) were identified and used to construct a diagnostic model with excellent predictive performance. Protein–protein interaction and immune infiltration analyses revealed that these genes are closely associated with immune cell activity, particularly the increased infiltration of resting CD4 memory T cells and M2 macrophages in the DR retina. To validate these findings, an STZ-induced diabetic mouse model was used, with key genes further validated at the protein level via Western blot. In addition, consensus clustering was used to stratify patients with DR into two molecular subtypes with distinct immune characteristics and pathway enrichment patterns. Overall, our study elucidates the immune-related mechanisms underlying DR and highlights PLAUR, PLAU, and VGF as potential immune-associated biomarkers, providing a theoretical basis for precision diagnosis and development of targeted immunotherapeutic strategies for DR.

  • Open Access

    Mapping the Global Scientific Landscape of Transcutaneous Electrical Nerve Stimulation for Multimodal Pain Management: A Bibliometric Analysis

    by Zhe Wang, Jinghui Huang, Lin Mu, Tingting Mai, Ying Li, Fanfu Fang

    Background: Pain severely affects the quality of life. Transcutaneous electrical nerve stimulation (TENS) is widely used for pain relief, but a systematic overview of its global research landscape is lacking. Methods: A total of 1493 articles were retrieved from the Web of Science Core Collection up to March 15, 2025. Bibliometric analyses were performed using CiteSpace, VOSviewer, bibliometrix, KH Coder, and latent Dirichlet allocation topic modeling. Results: The United States of America contributed the most publications, followed by China. The University of Iowa and Professor Kathleen A. Sluka were the most productive institution and author, respectively. The journal Pain was the most influential. Hotspots included knee osteoarthritis, low back pain, and chronic pain. Topic modeling identified 12 key themes covering clinical applications and mechanisms. Conclusion: TENS research in pain management is growing with increasing international collaboration. This study reveals research hotspots and trends to guide future studies.

  • Structural discrepancy and domain adversarial fusion network for cross-domain fault diagnosis

    by Fuzheng Liu, Faye Zhang, Xiangyi Geng, Lin Mu, Lei Zhang, Qingmei Sui, Lei Jia, Mingshun Jiang, Junwei Gao


  • Open Access

    Abnormal Levels of Serum Ferroptosis-Related Biomarkers in Diabetic Retinopathy

    by Lin Mu, Dahu Wang, Zhiguo Dong, Jiajun Wu, Xiaoyu Wu, Jing Su, Yinjian Zhang

    Purpose. This study aimed to measure the concentrations of ferroptosis-related biomarkers, namely, iron (Fe), lipid peroxide (LPO), reactive oxygen species (ROS), glutathione peroxidase-4 (GPX4), and glutathione (GSH) in DR in the attempt to evaluate the diagnostic performance of these biomarkers. Methods. This study included 30 NPDR patients, 30 PDR patients, and 30 healthy subjects matched in age and sex. The concentrations of Fe, LPO, ROS, GPX4, and GSH in serum of the subjects were measured. Results. Compared with the normal group, GPX4 and GSH concentrations were significantly lower, and LPO, Fe, and ROS concentrations were significantly higher in DR patients. Compared with the PDR group, the NPDR group had higher concentrations of LPO, Fe, and ROS and lower concentrations of GPX4 and GSH, but there was no statistical difference in Fe, GPX4, and GSH. ROC curve shows that ferroptosis-related biomarkers have accumulated accuracy in NPDR and PDR. Conclusion. This study shows that ferroptosis-related biomarkers may be involved in the pathological process of DR and can be used as one of the biomarkers of DR.


  • Open Access

    Mechanisms of Qing-Gan Li-Shui Formulation in Ameliorating Primary Open Angle Glaucoma: An Analysis Based on Network Pharmacology

    by Lin Mu, Zhiguo Dong, Yinjian Zhang

    Objective. In this study, we investigated the mechanism of Qing-Gan Li-Shui formulation (QGLSF) in treating primary open glaucoma (POAG) by network pharmacology and in vitro experiments. Methods. The active pharmaceutical ingredients (APIs) of GLQSF (prepared with Prunella vulgaris, Kudzu root, Plantago asiatica, and Lycium barbarum) were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and Yet Another Traditional Chinese Medicine database (YATCM). The targets of POAG were screened out with GeneCards, OMIM, PharmGKB, Therapeutic Target Database (TTD), and DrugBank databases. The Venny platform was used to summarize the core targets. Topological analysis was performed using Cytoscape3.8.0. A protein-protein interaction network was plotted by STRING online. The key targets were subjected to GO and KEGG enrichment analyses. Finally, the effects of APIs were verified by a model of chloride hexahydrate (CoCl2)-induced retinal ganglion cells-5 (RGC-5). Results. The main APIs were selected as quercetin (Que) by network pharmacology. Nine clusters of QGLSF targets were obtained by the PPI network analysis, including AKT-1, TP53, and JUN. KEGG enrichment analysis showed that these targets were mainly involved in the AGE-RAGE signaling pathway. By in vitro experiments, Que promoted cell proliferation. The secretion of AKT-1, TP53, JUN, AGE, and RAGE in the cell culture supernatant decreased, as shown by ELISA. The mRNA levels of AKT-1, TP53, JUN, and RAGE decreased, as shown by RT-PCR. QGLSF may employ the AGE-RAGE signaling pathway to counter POAG. Conclusion. This study preliminarily elucidates the efficacy and mechanism of QGLSF in the treatment of POAG.


  • Open Access

    Effect of arenobufagin on human pancreatic carcinoma cells

    by Tianjiao Wang, Zhumei Zhuang, Peng Zhang, Yueyue Wang, Lin Mu, Haifeng Jin, Lei Zhou, Xiaochi Ma, Rui Liang, Yuhui Yuan

    Pancreatic carcinoma (PC) is a deadly form of cancer with poor overall survival. Currently, chemotherapy such as gemcitabine and 5-fluorouracil (5-FU) are the most popular medications that can improve survival, but rapid drug-resistance makes the search for more effective drugs urgent. Upon looking for natural components to treat PC, it was found that arenobufagin, a cardiac glycosides-like compound, showed significant effects on the gemcitabine-resistant pancreatic carcinoma cell line Panc-1 and the gemcitabine-sensitive cell line ASPC-1 at nanomolar concentrations. The present study used MTT and clonogenic survival assays to examine survival and proliferation, and western blotting to assess changes in the associated mitogen activated protein kinase and phosphoinositide 3-kinase pathways and expression of apoptosis-related proteins. The current study also detected the cell cycle by flow cytometry. Arenobufagin inhibited cell survival and proliferation, decreased the phosphorylation of key downstream proteins of K-Ras, including protein kinase B and extracellular signal related kinase, induced cell cycle G2/M phase arrest and apoptosis, and downregulated the level of phosphorylated epidermal growth factor receptor. Notably, the present data also showed that arenobufagin can enhance the sensitivity of PC cells to gemcitabine and 5-FU. In conclusion, arenobufagin could enhance the effect of gemcitabine and 5-FU on PC cells by targeting multiple key proteins. Therefore, arenobufagin has potential as anadjuvant therapy for the treatment of PC.